Home > Cardiology > ESC 2020 > Hot Line Presentations > Antihypertensives also reduce CV risk in people with normal blood pressure

Antihypertensives also reduce CV risk in people with normal blood pressure

Presented By
Prof. Kazem Rahimi, University of Oxford, UK
Conference
ESC 2020
Trial
BPLTTC study
New research from the BPLTTC study supports the notion that people with normal blood pressure can prevent heart attacks and strokes by taking prophylactic blood pressure-lowering medication. These data will add fuel to the discussion of current and future blood pressure thresholds. Prof. Kazem Rahimi (University of Oxford, UK) presented a meta-analysis of data from 348,854 participants from 48 clinical trials [1]. Participants were divided according to whether they had a prior diagnosis of cardiovascular disease, then further stratified according to 1 of 7 blood pressure groups ranging from systolic blood pressures of <120 mmHg up to ≥170 mmHg at study entry. With an average follow-up of 4 years, the investigators noted a progressive reduction in relative risk of major cardiovascular events by roughly 10% for each 5 mmHg reduction in systolic blood pressure, including for th...


Please login to read the full text of the article.


If you have no account yet, please register now.





Posted on